Business / Finance

RSS

Ocean Nutrition Canada purchases Alicorp fish oil refining plant

Ocean Nutrition Canada (ONC) the world's largest Omega-3 ingredient supplier, today announced its acquisition of a fish oil refining plant in Piura, Peru. With the purchase of the plant, ONC will now offer its customers a completely integrated supply chain, from primary processing through to finished ingredient.

13 Feb 2012

Linden to acquire SeraCare

SeraCare Life Sciences, Inc., a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today announced that it has entered into a definitive agreement to be acquired by an affiliate of Linden Capital Partners, a Chicago-based private equity firm that focuses on middle market leveraged buyout investments in the healthcare and life science industries.

13 Feb 2012

Regeneron reports total revenues of $123.0M for fourth quarter 2011

Regeneron Pharmaceuticals, Inc. announced financial and operating results for the fourth quarter and full year 2011 and provided an update on development programs.

13 Feb 2012

Ensign acquires Connected Home Health

The Ensign Group, Inc., announced today that an Ensign subsidiary has acquired Connected Home Health, a small home health agency based in Portland, Oregon. The asset acquisition was effective as of February 10, 2012.

13 Feb 2012

Taro fourth quarter net sales increase 44.3% to $148.1 million

Taro Pharmaceutical Industries Ltd. today provided unaudited financial results for the quarter and full year ended December 31, 2011.

10 Feb 2012

Exelixis prices underwritten public offering of common stock

Exelixis, Inc. today announced the pricing of its underwritten public offering of 11,000,000 shares of newly issued common stock at a price to the public of $5.50 per share.

10 Feb 2012

Ironwood prices public offering of 5,250,000 shares of common stock

Ironwood Pharmaceuticals, Inc. announced today the pricing of an underwritten public offering of 5,250,000 shares of its Class A common stock at a price of $15.09 per share to the public. All of the shares are being offered by Ironwood.

9 Feb 2012

Cyanotech third quarter revenues increase to $6,706,000

Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the third quarter and first nine months of fiscal year 2012, ended December 31, 2011.

9 Feb 2012

Prestige Brands third quarter net revenues increase 17.3% to $106.3M

Prestige Brands Holdings, Inc. today announced results for the fiscal 2012 third quarter ended December 31, 2011, including net revenues of $106.3 million, an increase of 17.3% over the prior year's comparable quarter of $90.6 million.

9 Feb 2012

Valley Pain Consultants announces new office location

Valley Pain Consultants, a division of Valley Anesthesiology Consultants, announced the relocation of its Paradise Valley office to 3301 N. Miller Road, Suite 120, Scloottsdale, AZ 85251.

9 Feb 2012

Humana, HCA show brighter earnings picture though worries remain

Humana met analyst projections for the quarter and HCA stock shares are rebounding.

8 Feb 2012

Gerresheimer revenue increases 6.8% to EUR 1094.7m

Gerresheimer AG, one of the leading global partners to the pharma and healthcare industry, has closed the 2011 financial year with strong growth in revenues and profits. "Our revenues and profits have developed very positively in 2011.

8 Feb 2012

Elan fourth quarter total revenue increases 18% to $271.0 million

Elan Corporation, plc today reported its fourth quarter and full-year 2011 financial results.

8 Feb 2012

Alexion acquires Enobia Pharma

Alexion Pharmaceuticals, Inc. today announced that the Company has completed its previously announced acquisition of 100% of the capital stock of Enobia Pharma Corp., a private biopharmaceutical company focused on the development of therapies to treat patients with ultra-rare and life-threatening genetic metabolic disorders.

7 Feb 2012

Spectros 2011 sales revenue increases 69%

Spectros announced today that year-over-year sales revenue rose 69% in 2011. This is the fourth year in a row for double-digit revenue growth for Spectros since the current T-Stat Oximeter was launched in 2008.

7 Feb 2012

BD first quarter revenues increase 2.5% to $1.888 billion

BD, a leading global medical technology company, today reported quarterly revenues of $1.888 billion for the first fiscal quarter ended December 31, 2011, representing an increase of 2.5 percent from the prior-year period, or 2.4 percent on a foreign currency-neutral basis.

From BD (Becton, Dickinson and Company) 7 Feb 2012

Vitrolife fourth quarter sales increase 18% to SEK 95 million

Vitrolife AB: Fourth quarter - Sales increased by 19 percent in local currency. Sales were the highest ever for a single quarter and amounted to SEK 95 (81) million, corresponding to an increase of 18 percent in SEK.

7 Feb 2012

Genomic Health plans to establish wholly owned subsidiary

Genomic Health, Inc. today announced plans to establish a wholly owned subsidiary with the goal of improving the quality of diagnosis, communication and support for millions of patients and their families faced with common and rare genetic conditions.

7 Feb 2012

Mylan acquires two dermatological drugs from Valeant

Mylan Inc. today announced that it has successfully completed the acquisition of two dermatological products from Valeant Pharmaceuticals.

6 Feb 2012

Audax Group acquires Advanced Dermatology and Cosmetic Surgery

Audax Group announced it has completed the acquisition of Advanced Dermatology and Cosmetic Surgery. Headquartered in Maitland, Florida, ADCS is a dermatology-focused physician practice management company, with 53 company-affiliated dermatology clinics in Florida and Ohio providing clinical, cosmetic, and pathology services.

6 Feb 2012